Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients
Clinical trial NCT06292650 · RECRUITING
Trial details
- NCT number
- NCT06292650
- Sponsor
- Zhongmou Therapeutics
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-25
- Primary completion
- 2027-12-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.